Mobile Investor

 Stock Information
VELO (OMX)
Last Price: 2.02
Last Trade: 4:17 PM ET - Jul 29, 2014
Change: 0.02 down  (0.98%)
Open: 2.01
Close: 2.04
High: 2.06
Low: 2.01
52-Week High: 2.30
52-Week Low: 0.50
Volume: 1,170,533
 Recent News
Jul 28, 2014
Envarsus® Receives European Marketing Authorization for Treatment of Both Kidney and Liver Transplant Patients
Jun 30, 2014
Envarsus® XR Demonstrates Lower Treatment Failure Rate in African-Americans Compared to Twice-Daily Tacrolimus (Prograf®)
Jun 23, 2014
Veloxis Announces Positive Two-Year Results from Pivotal Phase 3 Study of Envarsus® XR (tacrolimus extended-release tablets) in de novo Kidney Transplant Patients
May 22, 2014
Warrant Programme - New Articles of Association
May 22, 2014
Veloxis Receives Positive Opinion from CHMP for Envarsus® for Treatment of Both Kidney and Liver Transplant Patients
 Events & Presentations
Nov 12, 2014
Interim Report for the 3rd Quarter — for the period 1 January to 30 September, 2014
Aug 20, 2014
Interim Report for the 2nd Quarter — for the period 1 January to 30 June, 2014
May 15, 2014
Conference Call Announcing Interim Report for first Quarter 2014
This is an optimized Investor Page for viewing on your mobile devices. To view our entire Investor Relations site, click here.
© 2014 Veloxis Pharmaceuticals AS